4
Changes in Ownership
Akebia Therapeutics, Inc. Filed Acc 0001209191-16-112923
SVP, General Counsel, Sec. sold 1,556 shares at $9.41 ($14,642)
From the SEC's structured data for this filing
Trades in this filing
Hadas Nicole R. · SVP, General Counsel, Sec.
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2016-04-04 | Sale : show line 1 in the form | −1,556 | $9.41 | $14,642 | 85,528 | D |
| Open-market sales · 1,556 sh · avg $9.41 · $14,642 | ||||||
Loading xslF345X03/doc4.xml…